Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantification of the DPP-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

NCT00683735 is registered in ClinicalTrials.gov with Michael A. Nauck as lead sponsor.

NCT NCT00683735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00683735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantification of the DPP-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis
Lead sponsor
Michael A. Nauck
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2009
Completion date
December 31, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes